Glioblastoma in multiple sclerosis: a case report

Giovanni Frisullo1, Agata Katia Patanella, Viviana Nociti

  • 1Department of Neuroscience, Institute of Neurology, Catholic University, Largo Agostino Gemelli, 8, Rome 00168, Italy.

Journal of Neuro-Oncology
|February 14, 2009
PubMed

Insights

T-bet, pSTAT1, and pSTAT3 expression in peripheral blood mononuclear cells (PBMCs) may help distinguish multiple sclerosis (MS) relapses from noninflammatory diseases like glioblastoma.

Area of Science:

  • Neuroimmunology
  • Oncology

Background:

  • Multiple sclerosis (MS) relapses and cerebral tumors can present with similar clinical and MRI findings.
  • Previous research indicated elevated T-bet, pSTAT1, and pSTAT3 in relapsing MS patients' mononuclear cells.

Observation:

  • A relapsing-remitting MS patient with new neurological signs due to glioblastoma multiforme did not show increased T-bet, pSTAT1, and pSTAT3 expression in peripheral blood mononuclear cells (PBMCs).

Findings:

  • The patient's condition suggests that T-bet, pSTAT1, and pSTAT3 expression levels in PBMCs may differ between MS relapses and noninflammatory neurological conditions.
  • This observation highlights potential biomarkers for differential diagnosis.

Implications:

  • T-bet, pSTAT1, and pSTAT3 expression in PBMCs could serve as a valuable tool to differentiate MS relapses from other diseases with overlapping symptoms.
  • This may improve diagnostic accuracy and patient management in neurology and neuro-oncology.